Eko Health
The Core 300 AI stethoscope was FDA-cleared on Jul 23 2026 and launched in the US on Oct 22 2026.
The Core 300 AI stethoscope received FDA 510(k) clearance on Jul 23 2026 and went on sale in the US on Oct 22 2026 (up to 35x amplification, active noise cancellation, on-device heart-data display; pediatric and adult) (Cardiovascular Business).
Details
The Core 300 is billed as the first stethoscope with analog and digital listening in one chestpiece. Its cleared AI flags suspected structural heart murmurs when paired with the Eko app. It costs $199, with AI analysis on an Eko+ subscription ($119.99 a year). Launches in Canada, the UK and parts of Europe are planned. Eko’s earlier FDA-cleared Low Ejection Fraction AI helps spot heart failure during a routine exam.
Timeline
Every dated event in the wiki that involves Eko Health, newest first.
- Eko Health launches the Core 300 AI stethoscope
Hybrid analog/digital stethoscope with AI murmur detection; $199 plus an Eko+ subscription for the AI analysis.
Connections
Nothing links here yet. See other orphaned articles.
Sources
- MobiHealthNews, “Eko Health launches AI-enabled stethoscope”
- Cardiovascular Business, “FDA clears new AI-enabled stethoscopes”